Wird geladen...
Preparation & in vitro evaluation of (90)Y-DOTA-rituximab
BACKGROUND & OBJECTIVES: Radioimmunotherapy is extensively being used for the treatment of non-Hodgkin's lymphoma (NHL). Use of rituximab, a chimeric anti-CD20 antibody directed against the CD20 antigen in combination with suitable beta emitters is expected to result in good treatment respo...
Gespeichert in:
| Veröffentlicht in: | Indian J Med Res |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Medknow Publications & Media Pvt Ltd
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4822370/ https://ncbi.nlm.nih.gov/pubmed/26997015 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0971-5916.178593 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|